PROVIDER PROFILE · NPI 1407910201

Peter Wolfe

Internal MedicineLos Angeles, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

1,657

Beneficiaries

—

Total drug cost

$1.5M

Distinct drugs

Brand share

39.5%

Top prescribed drugs

Bictegrav/Emtricit/Tenofov Ala99 claims

Ritonavir92 claims

Atorvastatin Calcium80 claims

Raltegravir Potassium79 claims

Emtricitabine/Tenofov Alafenam70 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

136

By payment type

Food and Beverage$3K

REFERRAL NETWORK

Where Peter Wolfe's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
Laboratory Corporation Of America Clinical Laboratory · San Diego, CA	33	134
CEDARS-SINAI MEDICAL CENTER	17	86

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history